The present invention includes mood disorders, anxiety disorders, schizophrenia, Alzheimer's disease, Parkinson's disease, Huntington's disease, eating disorders, hypertension, digestive disorders, drug addiction, epilepsy, cerebral infarction, cerebral ischemia, cerebral edema, Provided is a therapeutic or prophylactic agent for diseases such as head trauma, inflammation, immune-related diseases, and alopecia. Specifically, a condensed azole derivative represented by the general formula (I) or a pharmaceutically acceptable salt thereof having an arginine-vasopressin 1b receptor antagonistic action is provided. [Chemical 1]本発明は、気分障害、不安障害、統合失調症、アルツハイマー病、パーキンソン病、ハンチントン舞踏病、摂食障害、高血圧、消化器疾患、薬物依存症、てんかん、脳梗塞、脳虚血、脳浮腫、頭部外傷、炎症、免疫関連疾患、脱毛症等の疾患の治療又は予防剤を提供する。具体的には、アルギニン－バソプレッシン１ｂ受容体拮抗作用を有する、一般式（Ｉ）で表される縮合アゾール誘導体、又はその医薬上許容される塩を提供する。【化１】
